Koyfin Home > Directory > Health Care > Acorda Therapeutics > Long-Term Investments

Acorda Therapeutics Long-Term Investments Chart (ACOR)

Acorda Therapeutics annual/quarterly Long-Term Investments from 2012 to 2014.
  • Acorda Therapeutics Long-Term Investments for the quarter ending June 06, 2014 was $122m a 53.17% increase of 65m year over year
  • Acorda Therapeutics Long-Term Investments for the last 12 months ending June 06, 2014 was $122m a 53.17% increase of 65m year over year
  • Acorda Therapeutics Annual Long-Term Investments for 2013 was $93m a -6.50% decrease of -6m from 2012
  • Acorda Therapeutics Annual Long-Term Investments for 2012 was $99m
Other Cash Flow Metrics:
  • Acorda Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $78m a 23.00% increase of 18m year over year
  • Acorda Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $60m a 1.90% increase of 1m year over year
  • Acorda Therapeutics Total Revenue for the quarter ending December 12, 2018 was $69m a -53.52% decrease of -37m year over year
View Chart On Koyfin

Quarterly ACOR Long-Term Investments Data

06/2014$122m
03/2014$102m
12/2013$93m
09/2013$57m
06/2013$29m
03/2013$42m
12/2012$99m
09/2012$86m
06/2012$47m
03/2012$17m

Annual ACOR Long-Term Investments Data

2013$93m
2012$99m